Industry News
Taking immunosuppressives, anti-cancer drugs may reactivate hepatitis B
Feb 10, 2015
Individuals previously infected with the hepatitis B virus (HBV) who receive chemotherapy or immunosuppressive treatment may be at risk of reactivating the disease according to a summary of report... Read More
New approach to colorectal surgical care results in quicker recovery times and lower costs
Feb 10, 2015
New study utilizing the ACS NSQIP risk calculator demonstrates how a new protocol for colorectal surgical care improves patient outcomes and increases patient satisfactionA new multidisciplinary... Read More
New study sheds light on cancer stem cell regulation
Feb 10, 2015
Researchers identify signaling molecules in intestinal stem cells that can lead to tumors if left unregulated. The findings suggest a new approach to targeting intestinal cancers. Read More
Cell signaling pathway goes awry in common pediatric brain tumor
Feb 10, 2015
A new study by Johns Hopkins researchers links a well-known cell communication pathway called Notch to one of the most common -- but overall still rare -- brain tumors found in children. Read More
Salicylates, a class of NSAIDs, stop vestibular schwannomas growth
Feb 10, 2015
Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology's Program in Speech and Hearing Bioscience and Technology have demonstrated that... Read More
An 'ambulance' for the brain
Feb 10, 2015
Chemists at IRB Barcelona patent and present a shuttle capable of transporting molecules into the brain; this achievement could facilitate the treatment of diseases with no therapy available. Read More
Analysis: High-cost blood cancer drugs deliver high value
Feb 10, 2015
Amid the growing debate about the high price of powerful new drugs in the United States, a recent analysis suggests that breakthrough therapies for blood cancers may, in many cases and with some... Read More
Patients with detectable PSA post-prostatectomy should receive more aggressive radiation therapy
Feb 10, 2015
Ten-year post-treatment analysis of German ARO 96-02Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy should receive earlier, more... Read More
CNIO scientists link aggressiveness of chronic lymphocytic leukaemia to genetic variability
Feb 10, 2015
The genetic variability of a tumour could be a predictor for its aggressiveness: the greater the variability in gene expression, the more aggressive the tumour is likely to be. Read More
Taking immunosuppressives, anti-cancer drugs may reactivate hepatitis B
Feb 10, 2015
Individuals previously infected with the hepatitis B virus (HBV) who receive chemotherapy or immunosuppressive treatment may be at risk of reactivating the disease according to a summary of report... Read More
Previous Page Next Page